Procter & Gamble (NYSE:PG) Price Target Raised to $166.00

Key Points

• TD Cowen raised Procter & Gamble’s price target from $150 to $166 while maintaining a “hold” rating, implying virtually no upside from the stock’s $165.94 price. Analysts’ consensus rating is “Moderate Buy,” with an average target of $164.25.
• Procter & Gamble exceeded quarterly expectations, reporting $2.00 in EPS versus $1.89 expected and revenue of $23.28 billion, up 4% year over year.
• Rising commodity, energy and transportation costs remain a key risk; management estimates these pressures could reduce annual profit by approximately $1.4 billion despite solid sales growth.

Procter & Gamble (NYSE:PG - Get Free Report) had its price objective boosted by investment analysts at TD Cowen from $150.00 to $166.00 in a report released on Friday, Benzinga reports. The firm presently has a "hold" rating on the stock. TD Cowen's price target would indicate a potential upside of 0.04% from the company's current price.

Other research analysts have also issued research reports about the stock. Weiss Ratings reissued a "hold (c)" rating on shares of Procter & Gamble in a research report on Monday, September 21st. Wells Fargo & Company restated an "overweight" rating on shares of Procter & Gamble in a report on Friday. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $166.00 price target on shares of Procter & Gamble in a research report on Tuesday. Argus lowered Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Friday, August 7th. Finally, Evercore raised Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 price objective for the company in a research report on Tuesday, October 6th. Fourteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $164.25.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $165.94 on Friday. The firm has a fifty day simple moving average of $148.08 and a 200-day simple moving average of $146.99. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $167.25. The stock has a market capitalization of $385.41 billion, a price-to-earnings ratio of 25.07, a PEG ratio of 3.90 and a beta of 0.39.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. During the same period in the prior year, the firm earned $1.99 EPS. Procter & Gamble's quarterly revenue was up 4.0% compared to the same quarter last year. On average, sell-side analysts expect that Procter & Gamble will post 6.98 earnings per share for the current year.

Insider Buying and Selling

In other Procter & Gamble news, CEO Paul Gama sold 2,225 shares of the firm's stock in a transaction on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $323,381.50. Following the sale, the chief executive officer directly owned 51,124 shares in the company, valued at $7,430,362.16. This trade represents a 4.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc Pritchard sold 4,030 shares of the business's stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $579,473.70. Following the transaction, the insider owned 187,001 shares in the company, valued at approximately $26,888,873.79. The trade was a 2.11% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 15,135 shares of company stock worth $2,189,970. 0.23% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Procter & Gamble

Several institutional investors and hedge funds have recently added to or reduced their stakes in PG. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $26,000. Montgomery Financial Services LLC bought a new stake in shares of Procter & Gamble during the second quarter valued at approximately $28,000. Paladin Partners LLC acquired a new position in shares of Procter & Gamble in the second quarter valued at $29,000. Toews Corp ADV acquired a new position in shares of Procter & Gamble in the second quarter valued at $37,000. Finally, Evergreen Advisors LLC bought a new position in Procter & Gamble in the first quarter worth $37,000. 65.77% of the stock is currently owned by institutional investors.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Quarterly results exceeded expectations. Fiscal Q1 2027 adjusted earnings were $2.00 per share, above the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, surpassing estimates of roughly $22.80 billion. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Underlying growth was broad and volume-driven. Organic sales rose 4%, with volume contributing 2.4 percentage points. Laundry and home-care products were among the key contributors, while favorable product mix and productivity savings supported the earnings beat. Procter & Gamble: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Management raised its fiscal 2027 all-in sales-growth outlook. The updated forecast reflects the acquisition of Thorne and reinforces investor confidence in the company’s ability to sustain growth. The earnings beat and defensive appeal also attracted buyers as broader large-cap markets weakened, helping PG reach a new 52-week high. Procter & Gamble Boosts FY27 All-in-sales Growth Outlook
• Neutral Sentiment: Procter & Gamble’s long record of dividend increases and low-beta, defensive business model remain attractive to income-focused investors, particularly amid elevated interest rates and economic uncertainty.
• Negative Sentiment: Higher commodity, energy and transportation costs remain a major risk. Management expects these pressures to persist through fiscal 2027 and indicated they could reduce annual profit by approximately $1.4 billion, potentially limiting margin expansion despite solid sales growth. P&G flags bigger hit to annual profit from higher commodity costs

About Procter & Gamble

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.